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Abstract: BACKGROUND: The expression of microRNAs (miRNAs) is essential for the proper de-
velopment of the mammalian embryo. A maternal exposure to endocrine disrupting chemicals during
preimplantation bears the potential for transgenerational inheritance of disease through the epigenetic
perturbation of the developing embryo. A comprehensive assembly of embryo-specific miRNAs and
respective isoforms (isomiR) is lacking to date. We aimed at revealing the sex-specific miRNA expres-
sion profile of single porcine blastocysts developing in gilts orally exposed to exogenous estradiol-17 (E2).
Therefore we analyzed the miRNA profile specifically focusing on isomiRs and potentially embryo-specific
miRNAs. RESULTS: Deep sequencing of small RNA (small RNA-seq) result in the detection of miRNA
sequences mapping to known and predicted porcine miRNAs as well as novel miRNAs highly conserved
in human and cattle. A set of highly abundant miRNAs and a large number of rarely expressed miRNAs
were identified by using a small RNA analysis pipeline, which was integrated into a novel Galaxy work-
flow specifically benefits incompletely annotated species. In particular, orthologue species information
increased the total number of annotated miRNAs, while mapping to other non-coding RNAs avoided
falsely annotated miRNAs. Neither the low nor the high dose of E2 treatment (10 and 1000 µ E2/kg
body weight daily, respectively) affected the miRNA profile in blastocysts despite the distinct differen-
tial mRNA expression and DNA methylation found in previous studies. The high number of generated
sequence reads enabled a comprehensive analysis of the isomiR repertoire showing various templated
and non-templated modifications. Furthermore, potentially blastocyst-specific miRNAs were identified.
CONCLUSIONS: In pre-implantation embryos, numerous distinct isomiRs were discovered indicating a
high complexity of miRNA expression. Neither the sex of the embryo nor a maternal E2 exposure af-
fected the miRNA expression profile of developing porcine blastocysts. The adaptation to the continuous
duration of the E2 treatment might explain the lack of an effect.
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Abstract
Background: The expression of microRNAs (miRNAs) is essential for the proper development of the mammalian
embryo. A maternal exposure to endocrine disrupting chemicals during preimplantation bears the potential for
transgenerational inheritance of disease through the epigenetic perturbation of the developing embryo. A
comprehensive assembly of embryo-specific miRNAs and respective isoforms (isomiR) is lacking to date. We aimed at
revealing the sex-specific miRNA expression profile of single porcine blastocysts developing in gilts orally exposed to
exogenous estradiol-17β (E2). Therefore we analyzed the miRNA profile specifically focusing on isomiRs and
potentially embryo-specific miRNAs.
Results: Deep sequencing of small RNA (small RNA-seq) result in the detection of miRNA sequences mapping to
known and predicted porcine miRNAs as well as novel miRNAs highly conserved in human and cattle. A set of highly
abundant miRNAs and a large number of rarely expressed miRNAs were identified by using a small RNA analysis
pipeline, which was integrated into a novel Galaxy workflow specifically benefits incompletely annotated species. In
particular, orthologue species information increased the total number of annotated miRNAs, while mapping to other
non-coding RNAs avoided falsely annotated miRNAs. Neither the low nor the high dose of E2 treatment (10 and 1000
μ E2/kg body weight daily, respectively) affected the miRNA profile in blastocysts despite the distinct differential
mRNA expression and DNA methylation found in previous studies. The high number of generated sequence reads
enabled a comprehensive analysis of the isomiR repertoire showing various templated and non-templated
modifications. Furthermore, potentially blastocyst-specific miRNAs were identified.
Conclusions: In pre-implantation embryos, numerous distinct isomiRs were discovered indicating a high complexity
of miRNA expression. Neither the sex of the embryo nor a maternal E2 exposure affected the miRNA expression profile
of developing porcine blastocysts. The adaptation to the continuous duration of the E2 treatment might explain the
lack of an effect.
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Background
Endocrine disrupting chemicals (EDCs) are natural and
synthetic substances that may impact on health by deteri-
orating the endogenous hormone system [1, 2]. During the
preimplantation phase the embryo is specifically sensitive
towards EDC acting as transcriptional modulators [3, 4].
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Switzerland
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EDC may perturb the uterine milieu and thereby also
indirectly impose adverse transgenerational effects on the
developing embryo [5]. Depending on the time, dose and
EDC substance, the effects may be either detrimental or
only lead to minor effects in the targeted individual or
the subsequent offspring. Estradiol-17β (E2) is the most
potent endogenous estrogen in the body. Because it is
present in the environment and can adversely act on the
developing organisms, it is considered as an EDC [6, 7].
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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In pigs, embryo development is under maternal control
until the 4-cell stage. While embryonic genome activation
occurs at around 3 days post fertilization [8], both com-
pact morula and the subsequent blastocyst are formed in
the uterus at around 4–5 days after fertilization, respec-
tively [8]. At Day 7 of development, the embryo hatches
from the zona pellucida, increases in size until Day 10
of development [9] and starts to rapidly elongate by Day
11. At the same time, the embryo secretes E2 as primary
pregnancy recognition signal [10].
We have only recently shown that gestational low-
dose E2 treatment in pigs altered body composition and
bone development in male and female offspring, respec-
tively [6, 11]. Specifically, the oral application of very
low doses of E2 left a lasting epigenetic fingerprint in
both the mother and her offspring, revealed by differen-
tial gene expression and DNA methylation of cell cycle
regulation and tumor suppressor genes in a number of
different tissues [12]. An intergenerational effect of ges-
tational exposure was revealed as blastocysts not only
showed differential gene expression, but also differen-
tial local DNA methylation patterns largely similar to
the maternal tissues [12] (Flöter et al, under review). In
embryos of several species including mice, cattle, and
pigs, a dynamic developmental stage-specific microRNA
(miRNA) expression has been described [13–15]. In addi-
tion, it has been hypothesized that embryonic E2 in pigs
is also associated with changes in the expression of miR-
NAs in the embryo [13], which can lead to pregnancy
disruption [16].
In this study we focus on non-coding RNA (ncRNA)
which are transcripts that are not translated into pro-
teins and usually have structural or regulatory roles [17].
The corresponding genes are located in intergenic and
intronic regions or on the reverse strand of protein-coding
genes, but can also have similar structures as protein-
coding genes located within protein-coding sequences
[18]. Many known ncRNAs are assigned to different func-
tional classes [19] and play a pivotal role in gene expres-
sion regulation. Well-known long ncRNAs present in very
high amounts in the cell are rRNAs and tRNAs. Other
small ncRNA groups, such as long piRNAs and miRNAs
with sizes below 50 nt, have only lately been studied inten-
sively [20]. Due to the small size, the latter had been
difficult to discriminate from partially degraded longer
transcripts [21]. While piRNAs have been shown to medi-
ate transposon silencing and epigenetic gene regulation in
gametes [22], miRNAs comprise a large class of small ncR-
NAs involved in post-transcriptional repression of genes,
inhibition of messenger RNA (mRNA) translation and/or
enhanced mRNA degradation [23, 24]. MiRNAs are pro-
duced from a stem-loop-containing primary precursor
(pri-miRNA) [25] that is processed by the Drosha-DGCR8
complex into a precursor hairpin (pre-miRNA) of ∼70nt
length in the nucleus. The pre-miRNA is transported
into the cytoplasm where it is converted by Dicer to a
17–27 nucleotides long double stranded miRNA/miRNA*
duplex. One of the strands or sometimes both represents
the functional mature miRNA form that is incorporated
in the RNA-induced silencing complex (RISC). This com-
plex is able to target specific mRNAs [26]. MiRBase is
one of the databases for miRNA sequences. It perma-
nently increases driven by the deposition of results of
small RNA deep sequencing experiments and provides a
number of precursor and mature miRNAs that are con-
firmed based on mapping of small RNA deep sequencing
reads [27]. Small RNA sequencing (RNA-seq) data can be
analyzed similar to other transcriptome sequencing data
based on basic analysis pipelines including quality con-
trol, filtering, trimming, and adapter clipping followed by
mapping to a reference genome or transcriptome. How-
ever, for small RNA-seq data it is necessary to modify the
analysis pipeline. The first universal steps of the RNA-
seq analysis starting with quality control up to adapter
clipping are needed for every FastQ file analysis. For map-
ping the short miRNA sequences, a specialized mapping
strategy is required, e.g., the BWA aligner which works
best for well-annotated genomes [28] or the National
Center for Biotechnology Information (NCBI) BLASTn-
short specifically for short sequences [29]. The universal
steps as well as sequence alignment can be performed in
Galaxy [30–32].
In human and mouse, a great variation of ncRNA is
known compared to other mammalian species. A seri-
ous limitation appears when working with incompletely
annotated species such as livestock. Since the number of
annotated small ncRNAs is relatively low, it is very dif-
ficult to comprehensively and accurately annotate small
RNA data sets. IsomiRs are miRNA variants that origi-
nate from imprecise and alternative cleavage during the
pre-miRNA processing and post-transcriptional modifi-
cations [33, 34]. This results in different miRNA sta-
bility, sub-cellular localization and different target sites
[35]. Mature miRNA sequences can have variations at
the 3’ or 5’ end or both ends such as additions or dele-
tions. Modifications that do not match the precursor
are so-called “non-template” isomiRs and are of particu-
lar interest because these isomiRs might indicate active
miRNA function, i.e., were used for repression of target
mRNAs [36, 37]. Five-prime end isomiRs can have an
interesting role because this modification affects the seed
region of the miRNA which can lead to a different set of
targets [38, 39].
We used small RNA-seq analysis to investigate isomiR
expression, expression of blastocyst-specific miRNAs, and
effects of a maternal estradiol-17β exposure from fertil-
ization onwards until the day of analysis (Day 10) in single
porcine blastocysts.
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Methods
Animal trial and sampling
The experimental trial has been previously described
[6, 40]. In brief, estrous cycle synchronized German
Landrace sows (n=4-6/treatment) were inseminated with
sperm of the same single Pietrain boar. Starting from
insemination until Day 10, sows were fed with different
doses of estradiol-17β (E2; 1, 3, 5(10)-ESTRATRIEN-3,
17β-DIOL, Steraloids, Newport, USA), namely with 10
and 1000 μg E2/kg body weight twice daily, respectively,
or with 2 ml ethanol carrier only (control group). The
E2 concentrations were selected according to reference
values for humans referring to oral uptake levels [41]
and have been reported earlier [6]. The low dose cor-
responds to the no observed effect level (NOEL). One
hour after ingestion of the last dosing, sows were slaugh-
tered on Day 10 of pregnancy. The uterus was removed
and embryos were flushed from the uterus using 10 ml
phosphate-buffered saline (PBS) (autoclaved, pH 7.4) per
horn. All embryos were transferred into a petri-dish
containing PBS, washed twice and then single embryos
were snap-frozen in liquid nitrogen and stored at -80 °C.
Animals were only included in the RNA-seq analysis if
embryos were at the hatched blastocyst stage. Experi-
ments with sows were performed in accordance with the
International Guiding Principles for Biomedical Research
Involving Animals, as proposed by the Society for the
Study of Reproduction, with the European Convention on
Animal Experimentation and with the German Animal
Welfare Act.
Extraction of RNA and DNA
Total RNA and DNA from single embryos were extracted
as reported recently [12] using the AllPrep RNA/DNA
Micro Kit (Qiagen, Hilden, Germany) following the man-
ufacturers protocol for cells with slight modifications. In
brief, 700 μl of Buffer RLT Plus supplemented with 1%
β-mercaptoethanol was added to the frozen embryos.
Disruption was achieved by pipetting up and down and
by a single brief vortexing. Homogenization was per-
formed using a syringe and needle (20 G). After cen-
trifugation of the lysate using a DNA spin column,
the column was stored at 4 °C, while the flow-through
was processed following the protocol for “purification
of total RNA containing small RNAs from cells”. In
order to improve RNA purity, the column was incubated
with Buffer RPE at step D3 and D4 before centrifu-
gation for 4 min and 2 min, respectively. RNA elu-
tion was repeated using the first eluate to increase the
final concentration. The DNA was purified subsequently.
Samples were immediately put on ice. RNA and DNA
samples were stored at -80 °C and -20 °C, respectively.
Purity and quantity was assessed spectrophotometrically
using the NanoDrop 1000 (peqLab, Erlangen, Germany).
Additionally, RNA quantity of embryos was determined
using the Qubit (Invitrogen) with the Qubit™ RNA BR
Assay. RNA integrity was measured by means of the
Bioanalyzer 2100 (Agilent Technologies, Waldbronn,
Germany) with the RNA 6000 Nano Kit (Agilent). The
mean RNA Integrity Number of the embryo samples was
9.7 ± 0.3 (± SD).
Embryo sexing
RNA and DNA, extracted from at least four embryos
per sow from four sows per treatment group (control,
NOEL, high dose), were used (n = 65). The sex of the
embryos was determined by means of quantitative real-
time polymerase chain reaction using the DNA with
primers specific for the y- chromosomal gene SRY in addi-
tion to primers for the autosomal histone gene. Primers
were design using NCBI primer-Basic Local Align-
ment Search Tool (BLAST) [42]. The SuperScript III
PlatinumSYBRGreen One-Step qRT-PCR Kit (Invit-
rogen) was used on the LightCycler 2.0 (Roche Diag-
nostics GmbH, Mannheim, Germany). One microliter of
DNA was added to 9 μl of the master mix (5 μl of
2X SYBR  Green Reaction Mix (includes 0.4 mM
of each dNTP and 6 mM MgSO4), 2.4 μl of nuclease
free water, 1 μl of 20x Bovine Serum Albumin (ultra-
pure, non-acetylated) (1 mg/ml), 0.2 μl of forward primer
[20 μM], 0.2 μl of reverse primer [20 μM], and 0.2 μl
of SuperScript  III RT/Platinum  Taq Mix). PCR
was performed with the following thermal cycler pro-
gram: 50 °C for 10 min, 95 °C for 2 min, followed by
50 cycles for 5 s at 95 °C, 10 s at 60 °C, and 15 s at
72 °C. Melting curve analysis was performed from 55
to 95 °C with 0.1 °C/sec, then samples were cooled to
40 °C. Reactions were run in duplicates for each sam-
ple. A positive control DNA was included in each run.
Each primer pair was checked for specificity by sequenc-
ing the amplification product. The melting point was
used for confirmation of the identity of the product for
each reaction.
Small RNA sequencing
NEBNext  Small RNA libraries were prepared starting
from 50–100 ng total RNA from individual embryos (n=6
per group, 6 groups in total) and were sequenced as one
pool of 36 barcode-tagged samples on an Illumina HiSeq
4000 (126 bp single-end reads) on one lane. These six
groups consists of a control group (ethanol carrier only),
low dose (10 μg E2/kg), and a high dose (1000 μg E2/kg)
for male and female embryos, respectively. Sequencing
was performed at the Functional Genomics Center Zurich
and results uploaded as FastQ files to our local Galaxy
data storage (Galaxy-Platform version 15.10). NGS exper-
iments have been deposited in EBI ArrayExpress [43] with
accession number (E-MTAB-6201).
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Analysis of small RNA datasets derived from porcine
endometrium
Two small RNA-seq datasets derived from porcine
endometrium were used for comparison of miRNA
expression, namely one small RNA dataset for Day 10 of
pregnancy generated in a previous study in our group
[40], and another dataset for Day 12 of pregnancy
downloaded from Gene Expression Omnibus (GSE64863,
SRP052027) [13].
Processing of Fastq files
The data analysis was performed on our locally
installed Galaxy system [30]. In the first step of the
pipeline, adapter sequences were removed (Illumina
Universal Adapter: AGATCGGAAGAGCACACGTCT-
GAACTCCAGTCAC) with the tool “clip adapter”
(Version 1.0.1 FASTX-toolkit [44]). This tool allows
to keep clipped sequences and discard non-clipped
sequences. Next, Trimmomatic [45], (Version 0.36) was
used to remove N bases (any nucleotide, not a gap) at
the first position of the 5’ end which affected 15% of
all sequences due to a known sequencing issue of the
Illumina HiSeq 4000 instrument. All Fastq files were
quality checked after each processing step with FastQC
(v0.11.2) to control the performance of the processing
steps. The data analysis strategy was to generate a count
table for all obtained unique sequences. This count table
was the basis for the subsequent statistical analysis and
to annotate the sequences. For this, a series of standard
Galaxy tools were used as well as additional converting
tools from the ToolShed [46] (Additional file 1: Figure S1).
At first, each FastQ file was collapsed into the sequence
and number of appearance (using the tool “Collapse” -
FastxTools [44] ranked by the counts (Additional file 2:
Figure S2: no. 1). These FASTA files were converted into
Galaxy data file type ‘tabular’ (tab-separated text files)
with the tool “FASTA-to-Tabular” (Version 1.1.0) (Addi-
tional file 2: Figure S2: no. 2). In the following step of the
workflow (Additional file 2: Figure S2: no. 3-4) the rank
was removed from the table of each identifier generated
by the “Collapse” tool followed by two tools (Convert
and Cut) to extract the counts and sequence information.
With the tool “Convert” dashes were converted into tabs
and the columns of interest (counts and sequences) were
obtained using “Cut”. In the next step, all separate files
corresponding to the individual samples were joined into
one table based on the column with the sequences. To join
these tabular files, an in-house tool termed “Join datasets
by identifier column” was implemented (available in the
“ToolShed” Galaxys app store [46] “join_files_by_id”)
(Additional file 2: Figure S2: no. 5). The resulting table
contained the unique sequences and the number of reads
per sample. This count table was filtered to remove
sequences with negligible read counts, comprising
sequencing errors or sequences with very low evidence
for potential expression by using counts per million
(CPM) per sample [47]. The mean library size and poten-
tial CPM cutoff (Count table statistics, in house tool) was
calculated and the cutoff set to 2.64 CPM (corresponding
to an average of 20 reads per library) for at least 5 out of
36 libraries.
Annotation of filtered unique sequences
Filtered sequences were extracted “Tabular to FASTA” and
mapped with NCBI BLAST+ [32] blastn-short to align
them to all transcripts of Sus scrofa including non-coding
RNAs and related well-annotated species. The collection
of BLAST databases contained sequences from miRBase
(precursor and canonical mature miRNAs), transcript
sequences fromNCBI and Ensembl, including non-coding
RNAs, as well as tRNA and piRNA cluster sequences
retrieved from NCBI Sus scrofa 10.2 GFF3 file [48, 49]
(files: mirbase 21: mature/precursor, human, pig, and
cattle; Ensembl: predicted precursor sequences, human,
pig, cattle, plus other ncRNAs from pig and human;
NCBI: all RefSeq transcripts and other non-coding RNAs,
for human, pig, and cattle (E-MTAB-6201)). Finally, all
BLAST results were filtered and joined by removing all
duplicated hits. The annotated sequences were further
filtered for potential miRNAs and used for analysis of
differential expression. Therefore, we checked if all poten-
tial miRNAs also had a significant hit to tRNAs (from
pig) or rRNAs (from pig and human) and removed these
from the potential miRNAs. Filtering of the alignments
was done rather conservative by not allowing any mis-
match neither for mapping to porcine nor to the other
species (for detailed filtering options see Additional file 3:
Table S1).
Analysis of differential expression
The analysis of differential miRNA and isoform expres-
sion was performed with the BioConductor package
edgeR [50]. To estimate trended dispersions, first the
dataset was normalized on library size (TMM normal-
ized) [50] and the GLM robust (estimateGLMRobust-
Disp) [51] function was used to dampen the effect
of biological outliers. For comparison of the experi-
mental groups, the contrasts (1) male versus female
for all estradiol-17β doses and control in separate and
(2) low (10) and high (1000) dose versus control sep-
arately for male and female embryos were set. An
adjusted p-value (false discovery rate (FDR)) of 10%
and 5% was used as threshold for significance of differ-
entially expressed miRNA sequences. Expression values
(CPM) of identified differentially expressed sequences
(DES) were further processed with an R script to per-
form hierarchical cluster (HCL) analysis by samples
and DES [52].
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IsomiR analysis
IsomiRs were detected with a pipeline of several R
packages from BioConductor [53]. First, all anno-
tated sequences were assigned to their annotated
miRNA precursor and aligned with ClustalOmega
used by the R package msa [54, 55]. The alignment
was used to calculate added and deleted nucleotides
and compared to the annotated canonical mature
miRNA found in miRBase. In addition, the BLAST
result was used to characterize miRNA forms contain-
ing non-template nucleotides. Finally, the rank of all
isomiRs in their mature miRNA group was calculated
according to the individual read counts (expression
levels, CPM).
MiRDeep2 analysis
MiRDeep2 [56] was performed on our locally installed
Galaxy system. It allows the user to map small RNA-
seq reads against mature miRNA, precursor miRNA
and in addition to align all sequences to the cor-
responding genome. It is also capable of predicting
pre-miRNA folding structures of known and novel
miRNA genes. Prefiltered Fastq files (quality control
and adapter clipping) from our pipeline were used to
run first the miRDeep2 mapper (version 2.0.0) followed
by the main program to identify novel and known
miRNAs. For the comparison, the ARF output file of
the miRDeep2-mapper was used which provides all
mapped sequences. Additionally, the same miRNA anno-
tation files (see above) were used to map all miRNA
sequences.
Expression database search
The MiRmine - Human miRNA Expression Database was
used to search for the expression of human ortholog
miRNAs in different tissues [57]. This database provides
tissue-specific expression profiles and relative abundance
of miRNAs identified in different human miRNA studies.
Results
Processing and annotation of small RNA-seq reads
The sequencing of 36 small RNA-seq libraries for the
Day 10 blastocysts resulted in 8 to 32 million raw reads
per library. After joining all unique sequences and read
counts into one count table for all samples, ∼ 24,000,000
unique sequences were obtained. The count table was
reduced to ∼68,000 unique sequences by filtering on
>2.64 CPM corresponding to an average of ≥20 reads
per sample. Of these sequences, ∼45,000 sequences could
be assigned to known RNAs in the annotation files
(Additional file 4: Table S2). Themajority of the sequences
∼74% (∼70%) (percentage of read counts indicated in
parentheses, meaning the number of mapped sequences
per unique sequence) mapped to rRNAs, ∼6% (∼13%) to
miRNAs, and ∼8% (∼10%) to tRNAs, less than 1% (<1%)
of the sequences were assigned to piRNA clusters and
∼1% (<1%) to mRNAs (Fig. 1a). The remaining 11% (∼6%)
of sequences were mapped to other groups of ncRNAs.
With respect to read counts per RNA type we found large
differences between samples (Fig. 1b, Additional file 5:
Figure S3). For example, libraries varied from ∼ 6% to
∼42% in miRNA sequence content with respect to read
counts.
Fig. 1 Proportion of mapped reads and read counts: a The outer ring shows the percentages of different mapped unique sequences for different
types of RNAs. The inner ring represents the percentages of read counts per type of RNA., b The proportion of read counts is shown in percent of
each type according the different libraries
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Analysis of miRNA using a galaxy pipeline
The predominant length of all annotated miRNAs was
∼23 nt ranging from 16 nt for small isomiRs and 62 nt long
sequences mapping to precursor miRNAs. In total, 2949
unique sequences were assigned tomiRNAs ofmiRBase21
using all mature and precursor miRNAs from Sus scrofa,
Bos taurus and Homo sapiens (Additional file 6: Table S2).
Of these, 1842 (62%) sequences mapped to known miR-
NAs of Sus scrofa. In addition, we detected 1107 (38%)
sequences for novel porcine miRNAs, 443 (15%) map-
ping to Bos taurus and 623 (21%) Homo sapiens, and
41 (∼1%) to predicted Ensembl porcine novel miRNAs
(Additional file 7: Figure S4). Overall, 71 of these novel
miRNAs had also been assigned to a porcine pre-miRNA,
which indicates that they might not be novel miRNA
genes, but novel mature miRNAs. One-hundred-and-nine
sequences were filtered out because although annotated
as porcine miRNAs in miRBase, they were highly similar
to human rRNAs. Another 17 sequences were removed
due to their positive hit to porcine tRNA sequences
(Additional file 3: Table S2). Altogether, the sequences
reliably assigned tomiRNAs represented 257mature miR-
NAs. Of these miRNAs 162 were detected as known
porcine miRNAs (miRBase21) and 95 were novel miRNAs
for the pig which were assigned to known miRNAs from
human and cattle (Additional file 6: Table S3).
Comparison of galaxy pipeline to miRDeep2
The focus of the comparison of our pipeline to miRD-
eep2 was on mapping all reads to mature and precursor
miRNAs and compare the differences in isomiR content
and expression levels. Therefore a pre-result file including
all mapped miRNA isoforms was used within the miRD-
eep2 pipeline (Result file of miRDeep2.pl “Text output of
MiRDeep2”). MiRDeep2 detected 2862 potential miRNA
sequences after filtering on low expressed miRNAs (5 out
of 36 libraries > 20 reads each which is equal to the overall
expression of equal or greater 180 reads in total). Of those,
1788 were overlapping with our pipeline. Exactly 1074
sequences were assigned to miRNAs by miRDeep2 and
identified as false positives, 644 mapped to tRNAs, 193 to
rRNAs, and 38 to mRNAs. In addition, miRDeep found
199 miRNAs, which could not be mapped to known miR-
NAs but to other ncRNAs. Of themiRNA sequences, 1161
were uniquely annotated by our pipeline (Fig. 2). With
respect to expression levels, no significant differences in
reads counts were detected in comparison to miRDeep2.
Analysis of differential miRNA expression in response to
maternal estradiol-17β treatment and between female
andmale embryos
For the statistical analysis of miRNA expression, a filtered
count table was used containing 2892 annotated miRNA
sequences. None of the generated multiple scaling plot
(MDS) plots showed a grouping of embryo samples nei-
ther by treatment nor by sex (Fig. 3a, c, d, Additional
file 8: Figure S5). A grouping of embryos collected from
the same sow was observed in the MDS plots (Fig. 3b)
and in the pairwise distance heatmap (Additional file 9:
Figure S6). The comparison of male versus female
embryos did not reveal DES (FDR 5%). The comparison of
low dose estradiol-17β feeding versus control resulted in
20 DES for male embryos (FDR 5%), which represented 10
different mature miRNAs. The miRNA with the highest
number of DES was ssc-miR-34c. All other comparisons
did not detect DES (Additional file 10: Table S4). A HCL
analysis was performed for these 20 DES to characterize
the homogeneity of the expression within the treatment
groups (Fig. 4). The cluster analysis did not reveal a clear
grouping according to treatments and control. In addi-
tion, the read counts of isomiRs were summarized for
each miRNA and also female and male embryo samples
were joined for each treatment and the control group
to increase the number of replicates. Furthermore, the
embryos nested in the sow and further technical batch
effects were included in the statistical model. None of the
various analyses revealedmore reliable significant miRNA
expression differences.
Analysis of tissue-specific miRNA expression
To identify embryo-specific miRNAs potentially involved
in regulation of development, the embryo miRNA expres-
sion results were compared to two datasets from porcine
endometrium and to a miRNA expression database
(MiRmine). The data sets were analyzed with the same
pipeline and follow-up scripts. The expression levels of
the top 20 most frequently expressed miRNAs in the
embryo were compared. All three datasets had mir-
21 (miR-21-5p) as the most highly expressed miRNA
with 39% of all reads in Day 12 endometrium, 18%
in Day 10 endometrium and 22% in Day 10 embryos
(Additional file 11: Table S5, Fig. 5). In addition to com-
monly expressed miRNAs, potential tissue-specific miR-
NAs were identified. For this, we compared the top
10 expressed miRNAs of each study, which resulted
in 22 different miRNAs. For endometrium Day 10 or
Day 12, mir-143-3p (∼12% of all reads), let-7i, let-7f,
and let-7g (each ∼4% of all reads), mir-10b and mir-
10d (each ∼5%) were classified as potential embryo-
underrepresented miRNAs. Five miRNAs were identified
as potential embryo-enriched miRNAs (mir-371-5p 16%,
mir-302b 7%, mir-378 ∼5%, mir-7 ∼3%, and mir-302d
∼3%) (Fig. 6). These results were further validated by
a search in the miRmine miRNA expression database,
which contains expression data for human miRNA for
15 different tissues collected from a variety of deep
sequencing studies. The results showed that miR-371-
5p is also highly expressed in placenta and umbilical
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Fig. 2 Pipeline comparison: The Venn Diagram shows the overlap between our galaxy pipeline and the MirDeep2 pipeline on the level of detected
unique sequences [86]
plasma, and at considerable levels in testis, semen/sperm,
and salivary exosomes. Furthermore, high expression was
found in tumor tissues. MiR-302b-5p and miR-302d-5p
were not found as expressed in any dataset contained in
miRmine. MiR-378-5p is highly expressed in umbilical
plasma, blood macrophages, and other plasma and serum
samples. Lower expression was also found in testis, pla-
centa, and a variety of tumors. MiR-7-5p expression in the
miRmine data sets was very high in pancreas beta cells
and high in various plasma samples, testis, sperm, pla-
centa, serum, salivary exosomes, CD4+ T cells and CD19+
B cells from blood, and different tumor tissues. The most
dominant potential endometrium-specific miRNAs (mir-
148a-3p, let-7i, mir-30a-5p, let-7g, mir-143-3p) were all
equally high expressed in all 15 tissue types (Additional
file 12: Table S6). MiR-21-5p was highly expressed in all
tissues, which confirmed our findings from the compari-
son of embryo and endometrium.
IsomiR expression analysis
The top 30 highly expressed miRNAs represented ∼89%
of all read counts and the top 4 miRNAs ∼51%. Of
those, miR-21 was the most prominent, accounting for
∼22% of all miRNA read counts (Additional file 13:
Table S7, Fig. 5). On average, 5 isomiRs per mature
miRNA were detected (from 1 to 138). The greatest
variety of different isomiRs were expressed by ssc-miR-
371-5p (138) and ssc-miR-21 (67) (Additional file 14:
Table S8). Modification only at the 3’ end occurred
with 54% (1214), while 29% (649) had a modification
at both sides and 10% (215) only at the 5’ end. The
canonical form was found for 178 miRNAs (Fig. 7).
The variations from the canonical form found in miR-
Base were most frequently added bases rather than dele-
tions (Fig. 8a). At the 5’ end, most frequently one dele-
tion or one addition were found (Fig. 8b). At the 3’
end, one or two added nucleotides per isomiR occurred
most frequently (Additional file 14: Table S8, Fig. 8a).
Regarding the expression levels per isomiR, mostly the
canonical form was most abundant (∼68%), closely
followed by isomiRs with 3’ end modifications (25%)
(Fig. 9a). For miRNAs where the canonical form was
not present (89 miRNAs), the highest expression level
was detected for 3’ end modifications (∼ 61%), followed
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Fig. 3Multiple scaling plot of the top 200 on isomiR level: showing a the different treatment groups of male and female embryos with dose 0
(control), 10 (low) and 1000 (high), respectively (ng/μg E2 per kg body weight per day), b the grouping of the mother sows, c the grouping of the
different doses and d the grouping of female and male sex
by modifications at both sides (25%) and modifications
at the 5’ end (∼14%). Furthermore, the expression lev-
els of isomiRs were analyzed. For the expression anal-
ysis on isomiR level, low (on average less than 20
reads per sample) and moderate up to high expressed
isomiRs were defined (more than 20 reads per sample).
In total, 1003 isomiRs were identified with low expres-
sion (Additional file 15: Table S9) and 1946 sequences as
highly expressed. The isomiRs containing non-template
nucleotides sequences could be detected at 5’ end (398),
at 3’ end (1169) and or sequences that had modifications
on both sides (381) (Fig. 7b). The analysis of expres-
sion levels of all non-templated miRNAs revealed that
28 sequences with ∼10% of the 3’ end non-template
isomiRs and ∼ 3% of the 5’ non-template isomiRs
showed the highest expression of the corresponding
miRNA (Additional file 14: Table S8, Fig. 9b). The top 5
most frequently expressed miRNAs were hsa-miR-200a-
3p, bta-miR-21-5p, bta-miR-378d, bta-miR-1246, and ssc-
miR-210 ranging from ∼6000 till ∼62,000 read counts
equally distributed through all samples.
Discussion
In this study, we used core Galaxy tools complemented
with customized scripts to make the analysis of porcine
small RNA as straightforward as possible. We specifi-
cally included sequences of well-annotated species from
various sequence databases to improve the annotation of
the sequences found in the small RNA-seq results. This
strategy allowed the identification of sequence fragments
derived from rRNAs and tRNAs as well as other ncRNAs
or mRNAse. Furthermore, a strategy to analyze variant
isoforms of miRNAs (isomiRs) was developed [13, 58],
increasing the percentage of annotated sequences and
thereby adding additional information to the subsequent
statistical data analysis of each expressed small RNA.
Earlier studies aimed at standing the role of differ-
ential miRNA expression patterns in embryonic and
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Fig. 4 Heatmap of male low dose versus male control treatment (FDR 0.05): The x-axis shows the different samples of the two compared groups M0
and M10 (M0: male embryo control group; M10: male embryos low dose group). The y-axis shows the potential differentially expressed sequences
(isomiRs) obtained in the respective comparison. Mean-centered log2 CPM values are shown
Fig. 5 Embryonic miRNA: Top 20 expressed miRNAs: The percentage
of read counts assigned to the top 20 expressed miRNAs in addition
to the sum of all remaining miRNAs
fetal preimplantation development and in embryo/feto-
maternal interactions in pigs [13, 15, 59–62] (Flöter et
al, under review). In contrast, the present study focused
on the hatched blastocyst prior to conceptus elongation
and specifically explored effects of a maternal estradiol-
17β exposition on embryonic miRNA patterns. To our
knowledge, this is the first study investigating sex-specific
miRNA profiles including isomiRs of single preimplanta-
tion embryos.
Development of a small RNA-seq analysis pipeline for
incompletely annotated species
The pig served as large animal model for the effect of
endocrine disrupting chemicals in humans. Compared
to rodents, it better resembles the women regarding the
endogenous placental estrogen production during fetal
development [6]. However, working with incompletely
annotated species such as the pig makes the analysis
of small RNA-seq data sets much more difficult com-
pared to human or mouse. In pig, the miRNA anno-
tation is rather incomplete with respect to the rela-
tively low number of annotated miRNAs (342) that can
be found in miRBase (version 21). Therefore, a corre-
sponding analysis pipeline requires an approach that is
focused on annotation of new miRNAs. The approach
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Fig. 6 Tissue comparison: Top 10 expressed miRNAs in embryo Day 10, endometrium Day 10 and 12
used in the present study is based on sequence com-
parison (BLAST) of the sequences obtained from small
RNA-seq to various sequences derived from the pig, next
to different types of transcripts from cattle and human.
Since the generation of small RNA-seq libraries does
not specifically select miRNA sequences [63], further
potential source sequences have to be included such as
rRNAs, tRNAs, and other ncRNAs in addition to the
available precursor (pre-) and mature miRNAs. Particu-
larly, fragments of tRNAs, rRNAs or other small ncRNAs
Fig. 7 Detected miRNA isoforms (isomiR): The Venn Diagram on the left (a) represents the number of different detected isomiR on sequence level
organized by the modification types. The Venn Diagram on the right (b) represents the number of different detected isomiRs on sequence level split
into templated and non-templated forms
Bick et al. BMC Genomics  (2018) 19:590 Page 11 of 16
Fig. 8MiRNA modification differences: The barplot on the left (a) shows the percentage of isomiRs assigned to additions and deletions separated
by 3’ and 5’ end. The right (b) barplot represents the base variations of added and deleted bases for all detected miRNAs at 3’ and 5’ end
have been falsely identified as miRNAs based on their
respective size [64, 65]. The comparison of the results
of the new analysis pipeline to a standard miRNA anal-
ysis pipeline (miRDeep2) revealed differences and some
limitations, mainly on the side of miRDeep2. In partic-
ular, the mapping to other ncRNAs including tRNAs in
the new pipeline turned out to be a great improvement
to prevent misannotation of miRNAs. Both tools detected
similar numbers of miRNA sequences, but only 62% of
the sequences assigned to miRNAs were overlapping. The
analysis of the non-overlapping sequences revealed that
1074 potential miRNA sequences from themiRDeep2 tool
were derived from other ncRNAs such as rRNAs, tRNAs
or other ncRNA classes. Other studies also noticed the
problem of wrongly annotated miRNAs that were actually
derived from tRNAs [64, 65]. Venkatesh et al. stated that
such sequences would represent two new classes of regu-
latory non-coding small RNAs that are derived from the
cleavage of pre-existing tRNAs, namely tRFs and tiRNAs.
Schopman et al. (2010) concluded that such small RNA
fragments described as miRNAs in miRBase are likely
derived from tRNA processing. In our study, the respec-
tive sequences were present in a size range of miRNAs
up to about 100 nt and were all covering the same tRNA
sequence. Schopman et al. (2010) also concluded that the
rapid release of data from small RNA-seq projects would
lead to a misannotation of miRNAs in databases such as
miRBase. Especially sequences derived from fragments of
rRNAs and tRNAs are often highly abundant and present
in varying percentages in small RNA libraries. This might
Fig. 9 Top expressed isomiRs: The donut plot on the left (a) represents the top (rank 1) expressed isomiRs per miRNA group. The outer cycle shows
miRNA groups containing the canonical form (mature form of the database) and the inner ring are miRNA groups without the canonical form
present. The plot on the right (b) shows the top expressed isomiRs on sequence level organized by templated versus non-templated
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introduce a severe bias in estimating miRNA expression
levels and thereby affecting the detection of differentially
expressed miRNAs.
Effects of a maternal estradiol-17β treatment and of the
sex of the embryo onmiRNA expression in blastocysts
We recently demonstrated that the maternal low-dose
estradiol-17β treatment led to a perturbed endometrial
mRNA expression profile of sows as well as their devel-
oping blastocysts [12] (Flöter et al, under review). This
is of particular note, as low estradiol-17β doses, consid-
ered to exert no effect, were applied [6]. Because we found
a shift in body composition [6] and bone density [11] in
male and female offspring, respectively, we considered a
sex-specific intergenerational epigenetic epigenetic repro-
gramming imposed as early as the preimplantation phase.
Recently, it has been shown that the biogenesis of uter-
ine miRNAs is steroidal regulation [66]. Therefore, we
hypothesized that the maternal oral E2 exposure could
lead to an inference with normal miRNA expression in
the early embryo. This could be attributed to a direct
estradiol-17β impact on the embryo on the one hand or
through perturbations of the endometrial secretions due
to the estrogen treatment leading to changes in the uter-
ine milieu (Flöter et al, under review), that could in turn
have effects on the developing embryo.
Similar to the analysis of miRNA expression in the
endometrium samples (corresponding to the samples of
the present study), where miRNA expression was not
affected by E2 treatment, only small effects were found on
male Day 10 embryos. Since only a very low number of
miRNA sequences showed significant differences in male
embryos of the low dose group compared to controls and
the biological replicates did not group very well according
to treatment or sex in the cluster and principal component
analysis, it is difficult to say if these observations are true
expression differences in response to the E2 feeding. Fur-
thermore, despite some expression differences were found
in male embryos, differential miRNA expression between
female and male embryos was not detected. The observed
clustering of embryos collected from the same sow is most
likely attributed to a maternal effect on sibling embryos.
In addition, a similar developmental stage for siblings can
be assumed, since although the time point of fertilization
varies between sows, it is almost the same for siblings
within the same sow [67]. However, considering the sow
as batch effect in the statistical analysis did not change the
results. It is possible that not every sow and/or embryo
was affected by the treatment in the same way. However,
we did not find a difference in variation among the con-
trol and the treatment groups. Overall, from the obtained
results we can say that there is only a slight effect of
the maternal estradiol-17β feeding on miRNA expression
only in male embryos.
With respect to the experimental model, the time point
of the analysis may limit a generalization of the finding.
The sample collection was performed one hour after the
last estrogen dose, which might have been too late to
observe a very rapid miRNA response. On the contrary,
it is possible that the former ten days of treatment might
have led to an adaption of miRNA transcription. Further
studies are needed to verify the present findings. This
adaption might account for the difference to an earlier
study in which the singular exposure to estradiol-17β at
days 9 or 10 of pregnancy resulted in pregnancy failure
[16]. The pregnancy rate in our study, giving a continuous
treatment twice daily from fertilization until Day 10, was
not affected, not even in the high dose group [40]. The
treatment mode, namely i.m. injection versus oral appli-
cation in our study, most likely lead to a different steroid
metabolization possibly exerting the particular lack of an
effect in our case. It thus remains to be further unraveled
which circumstances estrogen treatment does not affect
the miRNA expression of a target tissue.
Interestingly, a sex-specific differential miRNA expres-
sion between embryos was likewise excluded. The HCL
analysis showed a partial clustering of embryos collected
from the same sow, which is most likely attributed to a
maternal effect on siblings embryos. In addition, a simi-
lar developmental stage for siblings can be assumed, since
although the time point of fertilization varies between
sows, it is almost the same for siblings within the same
sow [67].
Identification of potential embryo-specific miRNAs
The comparison of the embryo miRNA profiles to small
RNA-seq studies in porcine endometrium collected on
Day 12 [13] and Day 10 of pregnancy [40] identified not
only miRNAs with similar expression levels for some of
the most abundant miRNAs, but particularly also tissue-
specific miRNAs. Both endometrium and embryo sam-
ples are mixed tissues containing many different cell types
such as epithelial cells, fibroblasts, endothelial cells, and
various immune cells in the endometrium, and trophec-
toderm and embryoblast/hypoblast cells in the Day 10
blastocyst [68]. MiR-21 was highly expressed in both tis-
sues and the most abundant miRNA in the embryo as
well in Day 10 endometrium. A high expression of miR-
21 was also reported in other studies in porcine embryos
[69], oocytes [15], embryos of other species [14], and in a
variety of somatic tissues as well as cancer cells [70, 71].
Four miRNAs (miR-371-5p, miR-302a, miR-302b, and
miR-302d) were expressed only in blastocysts and not in
endometrium. MiR-371-5p is located within a pregnancy-
related miRNA cluster [72], and its increased expres-
sion has been found in the first compared to the third
trimester human placenta [73]. A database (miRmine)
search revealed its high expression in 9 (bladder, brain,
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breast, placenta, plasma, saliva, semen, sperm, and testis)
out of 15 tissues including placenta, which indicates a
tissue-specific expression. Mir-302b was not expressed
in any tissue contained in the database, which supports
our finding from the comparison to the endometrium
that miR-302b could be embryo-specific. MiR-371 and
miR-302a,b,d have been found specifically expressed in
human embryonic stem cells [74]. In the mouse, for
the homolog miRNA gene cluster to the human mir-
371-373 cluster (mir-290-295) and the mir-302 clus-
ter, specific expression in early embryos and embryonic
germ cells was found, and an important role in pluripo-
tency and embryonic development has been suggested
[75–77]. An upregulation of miR-302a, miR-302-b, and
miR-371-5p was found in porcine induced pluripotent
stem cells in comparison to porcine embryonic fibrob-
lasts [35]. In the same study, the mir-302 gene cluster
has been found to improve reprogramming efficiency.
On average we detected 5 isomiRs per miRNA. Interest-
ingly, for mir-302b, mir-302d, andmir-302a, which are not
yet contained in the miRBase for the pig (miRBase 21),
more different isoforms than the average were found (mir-
302b (23), mir-302d (33), and mir-302a (42). All potential
endometrium-specific miRNAs (mir-148a-3p, let-7i, mir-
30a-5p, let-7g, mir-143-3p) were highly expressed in all
15 tissue types included in the miRmine database. This
indicates that these miRNAs are not truly endometrium-
specific. As the endometrium is a complex tissue compris-
ing epithelial cells, fibroblasts, endothelial cells, and var-
ious immune cells, it remains to be determined in which
of the endometrial cell types these miRNAs are actually
expressed.
Analysis of isomiR expression in blastocysts
The analysis of isomiRs was performed according to a pre-
vious study investigating retina samples [78] to identify
templated and non-templated variations at the 5’ and 3’
end. Therein, more variations in form of deletions in com-
parison to the canonical form rather than added bases
have been found. Mostly, the isoforms were one base
shorter than the canonical which occurred more often
at the 5’ end. In contrast, the embryos displayed more
added bases and in general more variations at the 3’ end.
These could play a role in the effectiveness of miRNA
targeting. Specifically, 3’ non-templated adenylation of
the mature miRNA has been shown to interfere with
incorporation into the RISC [79], whereas monouridy-
lation of the pre-miRNA is required for processing by
Dicer for group II let-7 miRNAs [80] and oligouridylation,
in contrast, blocks uptake into Dicer [81, 82]. Adenyla-
tion at 3’ non-templated miRNAs tend to be higher with
∼35% compared to the other nucleotides C, G, and U
with ∼20% whereas modifications of uridine could not
be detected.
In addition, the distribution of expression level of differ-
ent isomiR types (canonical, templated, 3’ and 5’ modifica-
tions) was analyzed for the highest expressed miRNAs. In
accordance with Karali et al. (2016), the isomiR showing
the highest expression was mostly the canonical or tem-
plated form. Furthermore, in studies of human embryonic
stem cells [38] and human hepatocellular carcinoma [83]
different isomiRs resulting from deletions and additions at
the 5’ and 3 ’ side were identified and characterized. Con-
sistently, the authors found more modifications at the 3’
end compared to the 5’ end and concluded that this was
due to the greater constraint of the 5’ side. This finding is
also supported by the possibility of shifting the seed region
[84, 85], which can change the target mRNA spectrum.
In our analysis, we found a high number of non-
templated isomiRs of rather low expression level. Non-
templated isomiRs at the 3’ and 5’ end were only highly
abundant in ∼11% of all cases (rank 1). Due to the possi-
ble target change they are often not dominantly expressed
[83]. As a limitation of our data set, most of the dele-
tions of one nucleotide at the 5’ end were caused by the
removal of the first position of the obtained sequence
reads during quality trimming, since a “N” occurred at
the first position in 15% of all sequences. This issue was
derived from running the samples on the Illumina HiSeq
4000 instrument. However, five-prime non-templated
events may turn out to be of special interest in case
they can be shown to have a modified seed sequence
and thereby could have a different range of target
transcripts.
Conclusion
In conclusion, despite the lack of both sex-specificity
and the significancy of effects of a maternal estrogen
treatment on miRNA expression in blastocysts, the deep
sequencing of small RNAs in porcine blastocysts revealed
a high variety of expressed miRNAs and their isomiRs. A
catalog of isoforms of known porcine miRNAs and many
novel porcine miRNAs was generated indicating the high
complexity of miRNA expression and regulation in pre-
implantation embryo. Their role in embryo development
specifically related to the observed robustness towards
the maternal estrogenic treatment requires further
exploration.
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